0001209191-17-044235.txt : 20170706 0001209191-17-044235.hdr.sgml : 20170706 20170706191341 ACCESSION NUMBER: 0001209191-17-044235 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170703 FILED AS OF DATE: 20170706 DATE AS OF CHANGE: 20170706 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ADURO BIOTECH, INC. CENTRAL INDEX KEY: 0001435049 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 740 HEINZ AVENUE CITY: BERKELEY STATE: CA ZIP: 94710 BUSINESS PHONE: 510-848-4400 MAIL ADDRESS: STREET 1: 740 HEINZ AVENUE CITY: BERKELEY STATE: CA ZIP: 94710 FORMER COMPANY: FORMER CONFORMED NAME: ADURO BIOTECH DATE OF NAME CHANGE: 20080514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lew Jennifer CENTRAL INDEX KEY: 0001465994 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37345 FILM NUMBER: 17953595 MAIL ADDRESS: STREET 1: 2929 SEVENTH STREET, SUITE 100 CITY: BERKELEY STATE: CA ZIP: 94710 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-07-03 0 0001435049 ADURO BIOTECH, INC. ADRO 0001465994 Lew Jennifer C/O ADURO BIOTECH, INC. 740 HEINZ AVENUE BERKELEY CA 94710 0 1 0 0 Sr. Vice President of Finance Common Stock 2017-07-03 4 M 0 12000 0.82 A 54595 D Common Stock 2017-07-03 4 S 0 12000 11.136 D 42595 D Stock Option (Right to Buy) 0.82 2017-07-03 4 M 0 12000 0.00 D 2023-11-26 Common Stock 12000 83709 D The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2017. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.85 to $11.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Twenty-five percent of the shares subject to the Option vested on the first anniversary of the vesting commencement date of October 25, 2014, and the remainder vests in 36 equal monthly installments thereafter for the following three years. /s/ Jennifer Lew 2017-07-06